InvestorsHub Logo
Followers 15
Posts 1503
Boards Moderated 0
Alias Born 06/08/2015

Re: JCB5 post# 281

Thursday, 07/13/2017 5:14:45 PM

Thursday, July 13, 2017 5:14:45 PM

Post# of 550
TXMD The drug was in essence approved otherwise the pps would be substantially lower. The FDA had asked for additional 12on the study but the company had a type A meeting with the FDA and the results are due tomorrow. Most think the FDA will roll back their requirements. As to the losses well drug testing is very expensive and no one is buying g on the basis of past performance but rather future earnings. The shorts are always present with biotechnology as the FDA decisions create binary events. Tomorrow will tell the tale.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TXMD News